Skip to Main Content

Author Details

Pampee P Young
Vanderbilt University Medical Center
1996
113
37
PMIDPaper TitleJournal TitlePublished Year
36866426COVID-19 convalescent plasma donors: Unique motivations in unique times?Transfusion2023
37191295Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010-2019: A favorable sign of the resiliency of the platelet supply.Transfusion2023
37081734Considering equality in transfusion medicine practice.Br J Haematol2023
37070798Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma.Transfusion2023
34927291Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis.Transfusion2022
35841199Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations.Transfusion2022
35748490Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.Transfusion2022
35894539Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24â¿¿h after phlebotomy meets AABB quality standards.Transfusion2022
32533868Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.Vox Sang2021
33904604Implementation of measures to improve blood collection center employee safety and reduce callouts during the 2019 novel coronavirus pandemic.Transfusion2021
33616945Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.Transfusion2021
33665853Frequency of rare, serious donor reactions: International perspective.Transfusion2021
33780020Conservation of Rh negative Low Titer O Whole Blood (LTOWB) and the need for a national conversation to define its use in trauma transfusion protocols.Transfusion2021
33831224Paid platelet donors: Points to consider.Transfusion2021
34928960Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.PLoS Med2021
34275149In response.Transfusion2021
34013981International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses.Vox Sang2021
34013968International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.Vox Sang2021
34369863Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures.Blood Transfus2021
34331331Needed resiliency improvements for the National Blood Supply.Transfusion2021
33458811COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.Transfusion2021
33065652Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials.Ann Surg2021
33037643Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.Transfusion2021
32225150Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts.J Vis Exp2020
33615496Impact of primary culture: A true positive culture rate mystery.Transfusion2020
32052467An exploration of the advantages of automated titration testing: low inter-instrument variability and equivalent accuracy for ABO and non-ABO antibody titres relative to tube testing.Vox Sang2020
31898352Septic risk increases with apheresis platelet storage time.Transfusion2020
33460143In response.Transfusion2020
32885904Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.Pediatr Blood Cancer2020
32654200A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity.Transfusion2020
32898290Rural hospitals and access to platelets for treating active bleeding: Is the heartland bleeding?Transfusion2020
32297675Small proline-rich repeat 3 is a novel coordinator of PDGFRβ and integrin β1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts.FASEB J2020
32430950Adoption trends of point of issue Verax PGD rapid test for bacterial screening of platelets between 2013 and 2018 among hospitals supplied by the American Red Cross and impact on platelet availability.Transfusion2020
30980746Making whole blood for trauma available (again): the AMERICAN Red Cross experience.Transfusion2019
31289275Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing.Nat Commun2019
31194723Sepsis Attributed to Bacterial Contamination of Platelets Associated with a Potential Common Source - Multiple States, 2018.MMWR Morb Mortal Wkly Rep2019
29023757Acute autoimmune hemolytic anemia due to anti-En<sup>a</sup> autoantibody successfully treated with rituximab.Transfusion2018
30204955Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Transfusion2018
29415892Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis.JCI Insight2018
28886156Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs.PLoS One2017
29105829Significantly enhanced testing sensitivities of automated ORTHO VISION analyzers detect weak D phenotypes.Transfusion2017
27335371Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.FASEB J2016
28042617Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct.Cell Stem Cells Regen Med2016
25145464Cell-based therapies for cardiac disease: a cellular therapist's perspective.Transfusion2015
26268926Inhibition of Wnt/β-catenin pathway promotes regenerative repair of cutaneous and cartilage injury.FASEB J2015
26202213Reducing intraoperative red blood cell unit wastage in a large academic medical center.Transfusion2015
26172150Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion.Transfusion2015
25853746Effects of red-cell storage duration on patients undergoing cardiac surgery.N Engl J Med2015
25537659Prolonged hypoxia induces monocarboxylate transporter-4 expression in mesenchymal stem cells resulting in a secretome that is deleterious to cardiovascular repair.Stem Cells2015
25145580Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.Transfusion2015
  • 1 - 50 of 113

Recommended Authors

Mayo Clinic
Career Start Year 2009
Number of shared co-authors 28
Children's National Hospital
Career Start Year 2009
Number of shared co-authors 7
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 2
University of New Mexico
Career Start Year 2006
Number of shared co-authors 19
University of California san francisco
Career Start Year 2000
Number of shared co-authors 0
University of Minnesota
Career Start Year 1999
Number of shared co-authors 11
Department of Surgery University of Cincinnati College of Medicine
Career Start Year 1998
Number of shared co-authors 2
Goethe University, University Hospital Frankfurt
Career Start Year 1997
Number of shared co-authors 2
NewYork-Presbyterian/Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 3
Center for Biologics Evaluation and Research
Career Start Year 1996
Number of shared co-authors 6
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 2
Boston Children's Hospital
Career Start Year 1995
Number of shared co-authors 4
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 0
Department of Pharmaceutical Technology and Biopharmacy, University of Groningen
Career Start Year 1991
Number of shared co-authors 0
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1990
Number of shared co-authors 15
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 8
University of South Florida Morsani College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Cell Therapy Institute, Paracelsus Medical University (PMU)
Career Start Year 1987
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1986
Number of shared co-authors 3
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 1
Stony Brook Renaissances School of Medicine, Stony Brook University
Career Start Year 1984
Number of shared co-authors 9
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 6
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
La Jolla Pharmaceutical Company
Career Start Year 1983
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 0
Synthego Corporation
Career Start Year 1978
Number of shared co-authors 1
Center for Blood Oxygen Transport and Hemostasis, University of Maryland
Career Start Year 1974
Number of shared co-authors 18
Clinical Center, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 13

Collaborators

Johns Hopkins University
Co-authored papers 7
University of Minnesota
Co-authored papers 4
Vanderbilt University
Co-authored papers 4
University of Pittsburgh
Co-authored papers 4
Pittsburgh University
Co-authored papers 4
University of Maryland School of Medicine
Co-authored papers 3
Scientific Services
Co-authored papers 3
Surgical Outcomes Research Center, University of Virginia
Co-authored papers 2
Christian Medical College
Co-authored papers 2
Vitalant Research Institute
Co-authored papers 2
Emory University School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
University of New Mexico School of Medicine
Co-authored papers 2
Marcus Center for Cellular Cures, Duke University
Co-authored papers 2
University of Minnesota
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Co-authored papers 2
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Center for Biologics Evaluation and Research
Co-authored papers 1
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 1
Harborview Medical Center
Co-authored papers 1
College of Human Medicine, Michigan State University
Co-authored papers 1
Renaissance School of Medicine at Stony, Brook University
Co-authored papers 1
Brock University
Co-authored papers 1
Duke University Medical Center
Co-authored papers 1